Your browser doesn't support javascript.
loading
Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention.
Khoo, Bee Luan; Grenci, Gianluca; Lim, Joey Sze Yun; Lim, Yan Ping; Fong, July; Yeap, Wei Hseun; Bin Lim, Su; Chua, Song Lin; Wong, Siew Cheng; Yap, Yoon-Sim; Lee, Soo Chin; Lim, Chwee Teck; Han, Jongyoon.
Afiliação
  • Khoo BL; BioSystems and Micromechanics IRG, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore. beeluan@smart.mit.edu.
  • Grenci G; Mechanobiology Institute, National University of Singapore, Singapore, Singapore.
  • Lim JSY; Department of Biomedical Engineering, National University of Singapore, Singapore, Singapore.
  • Lim YP; BioSystems and Micromechanics IRG, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.
  • Fong J; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Yeap WH; Singapore Centre for Environmental Life Sciences Engineering, Singapore, Singapore.
  • Bin Lim S; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.
  • Chua SL; Department of Biomedical Engineering, National University of Singapore, Singapore, Singapore.
  • Wong SC; NUS Graduate School for Integrative Sciences & Engineering (NGS), National University of Singapore, Singapore, Singapore.
  • Yap YS; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Lee SC; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.
  • Lim CT; Department of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Han J; Department of Hematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.
Br J Cancer ; 120(4): 407-423, 2019 02.
Article em En | MEDLINE | ID: mdl-30713340

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Doxorrubicina / Aspirina / Anti-Inflamatórios / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Doxorrubicina / Aspirina / Anti-Inflamatórios / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2019 Tipo de documento: Article